SEC Form 4 · accession 0001179110-18-010749
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raul R Rodriguez
Officer — CEO, President · Director
Period of report
Aug 17, 2018
Accepted (ET)
Aug 21, 2018 · 7:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 17, 2018 | P | 114,000 | $2.6316 | A | 173,519 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $2.61 to $2.64. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price.
- F2Includes 2,502 shares that were purchased by the Reporting Person on June 29, 2018 under the Issuer's Employee Stock Purchase Plan.